Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 3
Submit an article Journal homepage
110
Views
1
CrossRef citations to date
0
Altmetric
Letter

The limit for chronic myeloid leukemia relapse after allogeneic hematopoietic stem cell transplant moves ever forward: when can you safely talk about healing?

Anna Paola IoriDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, ItalyCorrespondence[email protected]
,
Massimo BrecciaDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
,
Corrado GirmeniaDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
,
Salvatore PerroneDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
,
Veronica ValleDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
,
Fiammetta NatalinoDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
,
Walter BarberiDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
,
Emilia ScalzulliDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
,
Giovanni Fernando TorelliDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
,
Maria Cristina PuzzoloDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
&
Robin FoàDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Italy
 show all
Pages 669-670 | Received 20 May 2012, Accepted 21 Jul 2012, Published online: 04 Oct 2012

References

  • Thomas DE, Clift RA. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989;73:861–864.
  • Copelan EA, Crilley PA, Szer J, . Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia. Biol Blood Marrow Transplant 2009;15:851–855.
  • Mughai TI, Yong A, Szydlo RM, . Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse. Br J Haematol 2001;115:569–574.
  • Goldman JM, Majhail NS, Klein JP, . Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. J Clin Oncol 2010;28:1888–1895.
  • Robin M, Guardiola P, Devergie A, . A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors. Leukemia 2005;19:1613–1620.
  • Gabert J, Beillard E, van der Velden VH, . Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003;17:2318–2357.
  • Radich JP, Gehly G, Gooley T, . Polymerase chain-reaction detection of the bcr-abl fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 1995;85:2632–2638.
  • Miyamura K, Tahara T, Tanimoto M, . Long persistent bcr-ab1 positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. Blood 1993;81:1089–1093.
  • Roth MS, Antin JH, Ash R, . Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 1992;79:276–282.
  • Lin F, van Rhee F, Goldman JM, Cross NCP. Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 1996;87: 4473–4478.
  • van Rhee F, Lin F, Cross N, . Detection of residual leukemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukemia. Bone Marrow Transplant 1994;14: 609–612.
  • Serrano J, Roman J, Sanchez J, . Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse. Blood 1995;95:2659–2665.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.